51 Ces Urol 2024; 28(1): 46–51 KAZUISTIKY 2. Peeker R, Aldenborg F, Fall M. Nephrogenic adenoma – a study with special reference to clinical pre‑ sentation Br J Urol 1997; 80(4): 539–42, doi:101046/j1464-410x199700418x 3. Davis TA. Hamartoma of the urinary bladder Northwest Med 1949; 48(3): 182–5 4. Mazal PR, Schaufler R, Altenhuber-Müller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients N Engl J Med 2002; 347(9): 653–9, doi:101056/NEJMoa013413 5. Fournier G, Menut P, Moal MC, et al. Nephrogenic adenoma of the bladder in renal transplant recipi‑ ents: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term followup J Urol 1996; 156(1): 41–4 doi:101016/s0022-5347(01)65932-9 6. Khan I, Obeid M, Hasan N, et al. Nephrogenic Adenoma of the Urinary Bladder after Kidney Transplan‑ tation: Long-Term Follow-Up Case Rep Transplant 2020; 2020(8831966, doi:101155/2020/8831966 7. Tse V, Khadra M, Eisinger D, et al. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases Urology 1997; 50(5): 690–6 doi:101016/S0090-4295(97)00334-8 8. Venyo AK. Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature Int Sch Res Notices 2015; 2015(704982) doi:101155/2015/704982
RkJQdWJsaXNoZXIy NDA4Mjc=